Global Ovarian Cancer Therapeutics Market Size, Status and Forecast 2019-2025

Published On: February 2020 | Report ID: 10727 | Category: Pharmaceuticals and HealthcarePages: 165

Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products.

In 2018, the global Ovarian Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ovarian Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ovarian Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study

Bristol Myers Squibb Company

Eli Lilly and Company

GlaxoSmithKline Plc

Janssen Pharmaceuticals

Genentech Inc.

Astra Zeneca

Boehringer Ingelheim GmbH

Hoffmann La Roche Ltd.

Market segment by Type, the product can be split into

PARP

PD-L1

Angiogenesis Inhibitors

Market segment by Application, split into

Hosptial

Research

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Ovarian Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.

To present the Ovarian Cancer Therapeutics development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ovarian Cancer Therapeutics are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)

1.4.2 PARP

1.4.3 PD-L1

1.4.4 Angiogenesis Inhibitors

1.5 Market by Application

1.5.1 Global Ovarian Cancer Therapeutics Market Share by Application (2014-2025)

1.5.2 Hosptial

1.5.3 Research

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Ovarian Cancer Therapeutics Market Size

2.2 Ovarian Cancer Therapeutics Growth Trends by Regions

2.2.1 Ovarian Cancer Therapeutics Market Size by Regions (2014-2025)

2.2.2 Ovarian Cancer Therapeutics Market Share by Regions (2014-2019)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Ovarian Cancer Therapeutics Market Size by Manufacturers

3.1.1 Global Ovarian Cancer Therapeutics Revenue by Manufacturers (2014-2019)

3.1.2 Global Ovarian Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)

3.1.3 Global Ovarian Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.2 Ovarian Cancer Therapeutics Key Players Head office and Area Served

3.3 Key Players Ovarian Cancer Therapeutics Product/Solution/Service

3.4 Date of Enter into Ovarian Cancer Therapeutics Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Ovarian Cancer Therapeutics Market Size by Type (2014-2019)

4.2 Global Ovarian Cancer Therapeutics Market Size by Application (2014-2019)

5 United States

5.1 United States Ovarian Cancer Therapeutics Market Size (2014-2019)

5.2 Ovarian Cancer Therapeutics Key Players in United States

5.3 United States Ovarian Cancer Therapeutics Market Size by Type

5.4 United States Ovarian Cancer Therapeutics Market Size by Application

6 Europe

6.1 Europe Ovarian Cancer Therapeutics Market Size (2014-2019)

6.2 Ovarian Cancer Therapeutics Key Players in Europe

6.3 Europe Ovarian Cancer Therapeutics Market Size by Type

6.4 Europe Ovarian Cancer Therapeutics Market Size by Application

7 China

7.1 China Ovarian Cancer Therapeutics Market Size (2014-2019)

7.2 Ovarian Cancer Therapeutics Key Players in China

7.3 China Ovarian Cancer Therapeutics Market Size by Type

7.4 China Ovarian Cancer Therapeutics Market Size by Application

8 Japan

8.1 Japan Ovarian Cancer Therapeutics Market Size (2014-2019)

8.2 Ovarian Cancer Therapeutics Key Players in Japan

8.3 Japan Ovarian Cancer Therapeutics Market Size by Type

8.4 Japan Ovarian Cancer Therapeutics Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Ovarian Cancer Therapeutics Market Size (2014-2019)

9.2 Ovarian Cancer Therapeutics Key Players in Southeast Asia

9.3 Southeast Asia Ovarian Cancer Therapeutics Market Size by Type

9.4 Southeast Asia Ovarian Cancer Therapeutics Market Size by Application

10 India

10.1 India Ovarian Cancer Therapeutics Market Size (2014-2019)

10.2 Ovarian Cancer Therapeutics Key Players in India

10.3 India Ovarian Cancer Therapeutics Market Size by Type

10.4 India Ovarian Cancer Therapeutics Market Size by Application

11 Central & South America

11.1 Central & South America Ovarian Cancer Therapeutics Market Size (2014-2019)

11.2 Ovarian Cancer Therapeutics Key Players in Central & South America

11.3 Central & South America Ovarian Cancer Therapeutics Market Size by Type

11.4 Central & South America Ovarian Cancer Therapeutics Market Size by Application

12 International Players Profiles

12.1 Bristol Myers Squibb Company

12.1.1 Bristol Myers Squibb Company Company Details

12.1.2 Company Description and Business Overview

12.1.3 Ovarian Cancer Therapeutics Introduction

12.1.4 Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2014-2019)

12.1.5 Bristol Myers Squibb Company Recent Development

12.2 Eli Lilly and Company

12.2.1 Eli Lilly and Company Company Details

12.2.2 Company Description and Business Overview

12.2.3 Ovarian Cancer Therapeutics Introduction

12.2.4 Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2014-2019)

12.2.5 Eli Lilly and Company Recent Development

12.3 GlaxoSmithKline Plc

12.3.1 GlaxoSmithKline Plc Company Details

12.3.2 Company Description and Business Overview

12.3.3 Ovarian Cancer Therapeutics Introduction

12.3.4 GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2014-2019)

12.3.5 GlaxoSmithKline Plc Recent Development

12.4 Janssen Pharmaceuticals

12.4.1 Janssen Pharmaceuticals Company Details

12.4.2 Company Description and Business Overview

12.4.3 Ovarian Cancer Therapeutics Introduction

12.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2014-2019)

12.4.5 Janssen Pharmaceuticals Recent Development

12.5 Genentech Inc.

12.5.1 Genentech Inc. Company Details

12.5.2 Company Description and Business Overview

12.5.3 Ovarian Cancer Therapeutics Introduction

12.5.4 Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2014-2019)

12.5.5 Genentech Inc. Recent Development

12.6 Astra Zeneca

12.6.1 Astra Zeneca Company Details

12.6.2 Company Description and Business Overview

12.6.3 Ovarian Cancer Therapeutics Introduction

12.6.4 Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2014-2019)

12.6.5 Astra Zeneca Recent Development

12.7 Boehringer Ingelheim GmbH

12.7.1 Boehringer Ingelheim GmbH Company Details

12.7.2 Company Description and Business Overview

12.7.3 Ovarian Cancer Therapeutics Introduction

12.7.4 Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2014-2019)

12.7.5 Boehringer Ingelheim GmbH Recent Development

12.8 Hoffmann La Roche Ltd.

12.8.1 Hoffmann La Roche Ltd. Company Details

12.8.2 Company Description and Business Overview

12.8.3 Ovarian Cancer Therapeutics Introduction

12.8.4 Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2014-2019)

12.8.5 Hoffmann La Roche Ltd. Recent Development

13 Market Forecast 2019-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2019-2025)

13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@magnifierresearch.com

Phone: +1-201-465-4211

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.